Cryo-Cell International (CCEL) CEO Portnoy received 50,000 Stock Option
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
David Portnoy (Chairman, Co-CEO at Cryo-Cell International Inc., CCEL) reported that they received 50,000 Stock Option on Jan 21, 2025.
- Reporting person
- Portnoy David
- Role
- Chairman, Co-CEO
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | Grant or award (A) | Stock OptionOn 50,000 Common Stock6 | +50,000 | $8.08 | $404K | 50,000 direct |
Holdings before and after
- Stock Option: 0 to 50,000 direct
Other positions listed
- Common Stock: 804,742 direct
- Common Stock: 117,012 indirect, By 401K
- Common Stock: 230,621 indirect, By IRA
- Common Stock: 102,586 indirect, By Spouse
- Common Stock: 152,882 indirect, By Corporation
- Common Stock: 15,611 indirect, as Custodian for daughter
- Common Stock: 59,027 indirect, By LLC
- Common Stock: 55,219 indirect, By Corporation
- Common Stock: 11,352 indirect, As Custodian for son
- Common Stock: 11,242 indirect, As Custodian for son
- Common Stock: 10,783 indirect, As custodian for son
Footnotes from the filing
- 1. Shares of common stock held by Mayim Limited Partnership as is David Portnoy may be deemed the beneficial owner as the managing member and owner of Mayim Management, LLC, which is the general partner of Mayim Management Limited Partnership, which is the general partner of Mayim Investment Limited Partnership.
- 2. Shares of common stock held by uTIPu, Inc. as to which David Portnoy may be deemed the beneficial owner as the Chairman of the Board and Secretary.
- 3. Stock options will vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term.
- 4. 8,750 stock options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026.
- 5. Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.
- 6. Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Portnoy report in this CCEL Form 4?
David Portnoy (Chairman, Co-CEO at Cryo-Cell International Inc., CCEL) reported that they received 50,000 Stock Option on Jan 21, 2025.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for CCEL
Earlier insider filings at CCEL
- Jan 23, 2025SEC Form 4 filed by VP Finance, CFO Taymans Jill M
- Jan 23, 2025SEC Form 4 filed by Co-CEO Portnoy Mark L.
- Nov 14, 2024Chief Information Officer Mikulinsky Oleg exercised 20,000 shares at a strike of $3.77, increasing direct ownership by 24% to 104,349 units (SEC Form 4)
- Oct 31, 2024SEC Form 4 filed by Director Berger Harold D.
- Dec 28, 2023SEC Form 4 filed by Taymans Jill M
Quantisnow market dataAMEX
CCEL
Cryo-Cell International Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Misc Health and Biotechnology Services
- Listed since
- 2022
Get push alerts for CCEL
Full CCEL profile on Quantisnow Follow CCEL and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time